{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:49Z","timestamp":1786118869942,"version":"build-2736575974"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1097\/inf.0b013e3180616c8f","type":"journal-article","created":{"date-parts":[[2007,6,21]],"date-time":"2007-06-21T04:03:11Z","timestamp":1182398591000},"page":"632-638","source":"Crossref","is-referenced-by-count":42,"title":["Increasing Coverage and Efficiency of Measles, Mumps, and Rubella Vaccine and Introducing Universal Varicella Vaccination in Europe"],"prefix":"10.1097","volume":"26","author":[{"given":"Timo","family":"Vesikari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Sadzot-Delvaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Rentier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Gershon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210202","first-page":"65","article-title":"Progress towards elimination of measles and prevention of congenital rubella infection in the WHO European Region, 1990\u20132004.","volume":"80","year":"2005","journal-title":"Wkly Epidemiol Rec"},{"key":"R2-16-20210202","first-page":"324","article-title":"Mumps cases on the rise in England and Wales.","volume":"330","author":"Dobson","year":"2005","journal-title":"BMJ"},{"key":"R3-16-20210202","first-page":"171","article-title":"Epidemiology and Prevention of Vaccine-Preventable Diseases. 9th ed.","year":"2006"},{"key":"R4-16-20210202","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/00006454-200210000-00009","article-title":"Hospitalizations for varicella in the United States, 1988 to 1999.","volume":"21","author":"Galil","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"R5-16-20210202","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/315714","article-title":"Varicella mortality: trends before vaccine licensure in the United States, 1970\u20131994.","volume":"182","author":"Meyer","year":"2000","journal-title":"J Infect Dis"},{"key":"R6-16-20210202","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.287.5.606","article-title":"Varicella disease after introduction of varicella vaccine in the United States, 1995\u20132000.","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA"},{"key":"R7-16-20210202","article-title":"Harrison's Principles of Internal Medicine.","author":"Whitley","year":"2005"},{"key":"R11-16-20210202","first-page":"235","article-title":"Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut \/Stand: Juli 2004.","volume":"30","year":"2004","journal-title":"Epidemiol Bull"},{"key":"R12-16-20210202","first-page":"196","article-title":"Chickenpox outbreak in Herrera del Duque, Badajoz, Spain.","volume":"17","author":"Valades","year":"2003","journal-title":"Gac Sanit"},{"key":"R13-16-20210202","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1023\/A:1020066806544","article-title":"The incidence of chickenpox in the community. Lessons for disease surveillance in sentinel practice networks.","volume":"17","author":"Fleming","year":"2001","journal-title":"Eur J Epidemiol"},{"key":"R15-16-20210202","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/01.inf.0000122606.88429.8f","article-title":"Consensus: varicella vaccination of healthy children\u2014a challenge for Europe.","volume":"23","author":"Rentier","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R16-16-20210202","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/00006454-199905000-00004","article-title":"Epidemiology and cost analysis of varicella in Italy: results of a sentinel study in the pediatric practice. Italian Sentinel Group on Pediatric Infectious Diseases.","volume":"18","author":"Fornaro","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"R17-16-20210202","first-page":"1","article-title":"SIMInews no. 3.","volume":"13","author":"Salmaso","year":"2000","journal-title":"Boll Sist Informatizzato Mal Infet Notiziario dell'lst Superiore Sanita"},{"key":"R19-16-20210202","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/bmj.323.7321.1091","article-title":"Deaths from chickenpox in England and Wales 1995\u20137: analysis of routine mortality data.","volume":"323","author":"Rawson","year":"2001","journal-title":"BMJ"},{"key":"R20-16-20210202","first-page":"213","article-title":"Chickenpox increasingly affects preschool children.","volume":"3","author":"Ross","year":"2000","journal-title":"Commun Dis Public Health"},{"key":"R21-16-20210202","first-page":"224","article-title":"WHO-UNICEF joint statement on strategies to reduce measles mortality worldwide.","volume":"77","year":"2002","journal-title":"Wkly Epidemiol Rec"},{"key":"R25-16-20210202","first-page":"130","article-title":"Measles vaccines.","volume":"79","year":"2004","journal-title":"Wkly Epidemiol Rec"},{"issue":"suppl 1","key":"R26-16-20210202","first-page":"S17","article-title":"Evolution of measles elimination strategies in the United States.","volume":"189","author":"Hinman","year":"2004","journal-title":"J Infect Dis"},{"issue":"51\/52","key":"R27-16-20210202","first-page":"Q1","article-title":"Recommended immunization schedules for persons aged 0\u201318 years\u2014United States, 2007.","volume":"55","year":"2007","journal-title":"MMWR"},{"issue":"suppl 1","key":"R28-16-20210202","first-page":"131","article-title":"An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.","volume":"189","author":"Zhou","year":"2004","journal-title":"J Infect Dis"},{"key":"R29-16-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/jinf.2001.0930","article-title":"MMR vaccine: review of benefits and risks.","volume":"44","author":"Miller","year":"2002","journal-title":"J Infect"},{"key":"R30-16-20210202","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1001\/jama.284.20.2643","article-title":"Mumps and rubella eliminated from Finland.","volume":"284","author":"Peltola","year":"2000","journal-title":"JAMA"},{"key":"R31-16-20210202","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/jama.1996.03530270064033","article-title":"Measles elimination in the Americas. Evolving strategies.","volume":"275","author":"de Quadros","year":"1996","journal-title":"JAMA"},{"issue":"suppl 1","key":"R33-16-20210202","first-page":"S227","article-title":"Measles eradication in the Americas: progress to date.","volume":"189","author":"de Quadros","year":"2004","journal-title":"J Infect Dis"},{"key":"R34-16-20210202","first-page":"1044","article-title":"Measles epidemic attributed to inadequate vaccination coverage\u2014Campania, Italy, 2002.","volume":"52","year":"2003","journal-title":"MMWR. Morb Mortal Wkly Rep"},{"issue":"suppl 1","key":"R35-16-20210202","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1086\/368046","article-title":"Progress toward measles elimination in Germany.","volume":"187","author":"Hellenbrand","year":"2003","journal-title":"J Infect Dis"},{"key":"R37-16-20210202","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/01.inf.0000172900.70430.c2","article-title":"Effectiveness of measles vaccination after household exposure during a measles outbreak: a household contact study in Coburg, Bavaria.","volume":"24","author":"Arenz","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R38-16-20210202","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1016\/j.vaccine.2004.10.020","article-title":"The effectiveness of the mumps component of the MMR vaccine: a case control study.","volume":"23","author":"Harling","year":"2005","journal-title":"Vaccine"},{"key":"R39-16-20210202","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1016\/j.vaccine.2004.02.001","article-title":"Outbreak of mumps in a vaccinated child population: a question of vaccine failure?","volume":"22","author":"Vandermeulen","year":"2004","journal-title":"Vaccine"},{"key":"R40-16-20210202","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/bmj.330.7500.1132","article-title":"Mumps and the UK epidemic 2005.","volume":"330","author":"Gupta","year":"2005","journal-title":"BMJ"},{"key":"R42-16-20210202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2807\/esm.09.05.00468-en","article-title":"Interruption of measles transmission in Gipuzkoa (Basque Country), Spain.","volume":"9","author":"Cilla","year":"2004","journal-title":"Euro Surveill"},{"key":"R43-16-20210202","first-page":"E050303","article-title":"Large ongoing rubella outbreak in religious community in the Netherlands since September 2004.","volume":"10","author":"Hahn\u00e9","year":"2005","journal-title":"Euro Surveill"},{"key":"R44-16-20210202","first-page":"E050519","article-title":"Rubella outbreak in an unvaccinated religious community in the Netherlands spreads to Canada.","volume":"10","author":"Hahn\u00e9","year":"2005","journal-title":"Euro Surveill"},{"key":"R45-16-20210202","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ypmed.2004.04.036","article-title":"Declining seroprevalence of rubella antibodies among young Israeli adults: a 12-year comparison.","volume":"39","author":"Huerta","year":"2004","journal-title":"Prev Med"},{"key":"R46-16-20210202","first-page":"235","article-title":"Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am Robert Koch-Institut\/Stand: Juli 2006.","volume":"30","year":"2006","journal-title":"Epidemiol Bull"},{"key":"R47-16-20210202","first-page":"E050324","article-title":"Decline in measles in WHO European Region but rubella remains high.","volume":"10","author":"Muscat","year":"2005","journal-title":"Euro Surveill"},{"key":"R49-16-20210202","first-page":"333","article-title":"Interventionsprogramm Masern, Mumps, Roteln (MMR) Konzept fur ein nationales Programm zur Eliminierung der Masern in der Bundesrepublik Deutschland (September 1999).","volume":"45","year":"1999","journal-title":""},{"key":"R51-16-20210202","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00103-002-0412-5","article-title":"Erste Ergebnisse zum Impfstatus aus der Pilophase des Kinder\u2014und Jugendgesundheitssurveys.","volume":"45","author":"Dippelhofer","year":"2002","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"R52-16-20210202","first-page":"79","article-title":"Bek\u00e4mpfung der M\u00e4sern und konnatalen R\u00f6teln: WHO-Strategie in der Europ\u00e4ischen Region und aktueller Stand in Deutschland.","volume":"10","year":"2004","journal-title":"Epidemiol Bull"},{"key":"R53-16-20210202","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1007\/s00103-004-0952-y","article-title":"Ausgew\u00e4lhlte Daten zum Impf\u2014und Immunstatus in Deutschland.","volume":"47","author":"Reiter","year":"2004","journal-title":"Bundesgesundheitsblatt GesundheitsforschungGesundheitsschutz"},{"issue":"Supplementum VIII","key":"R55-16-20210202","first-page":"1","article-title":"Impfplan f\u00fcr routinem\u00e4ssige Schutzimpfungen. Stand August 2001. Ordner \u201cInfektionskrank-heiten\u2014Diagnose und Bek\u00e4mpfung.\u201d","year":"2001","journal-title":"Bull BAG"},{"key":"R57-16-20210202","first-page":"29","article-title":"Bulletin epidemiologique hebdomadaire. Calendrier vaccinal 2005 et autres avis du conseil superieur dhygiene publique de France relatifs a la vaccination.","volume":"142","year":"2005","journal-title":""},{"key":"R58-16-20210202","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1045-1870(03)00034-7","article-title":"Measles-mumps-rubella vaccine and the development of autism.","volume":"14","author":"Miller","year":"2003","journal-title":"Semin Pediatr Infect Dis"},{"key":"R59-16-20210202","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.inf.0000250689.09396.21","article-title":"Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella (MMRV) vaccine in healthy children aged 5\u20136 years.","volume":"26","author":"Vesikari","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R60-16-20210202","first-page":"17","article-title":"Global Advisory Committee on Vaccine Safety, 16\u201317 December 2002.","volume":"78","year":"2003","journal-title":"Wkly Epidemiol Rec"},{"key":"R62-16-20210202","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1440-1754.2005.00717.x","article-title":"Varicella vaccination in Australia.","volume":"41","author":"Macartney","year":"2005","journal-title":"J Paediatr Child Health"},{"key":"R63-16-20210202","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2807\/esm.10.01.00511-en","article-title":"Varicella zoster virus vaccination policies and surveillance strategies in Europe.","volume":"10","author":"Pinot de Moira","year":"2005","journal-title":"Euro Surveill"},{"key":"R65-16-20210202","first-page":"1","article-title":"National Advisory Committee on Immunization (NACI) update on varicella.","volume":"30","year":"2004","journal-title":"Can Commun Dis Rep"},{"key":"R66-16-20210202","first-page":"235","article-title":"Neuerungen in den aktuellen Empfehlungen der St\u00e4ndigen Impfkommission (STIKO) am RKI vom Juli 2006.","volume":"32","year":"2006","journal-title":"Epidemiol Bull"},{"key":"R67-16-20210202","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.inf.0000114906.78716.64","article-title":"Use of a computerized database to study the effectiveness of an attenuated varicella vaccine.","volume":"23","author":"Passwell","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R71-16-20210202","first-page":"257","article-title":"Childhood immunisation schedule of the Spanish Association of Pediatrics 2003.","volume":"58","year":"2003","journal-title":"An Pediatr (Barc)"},{"key":"R72-16-20210202","first-page":"846","article-title":"\u00dcbertragbare Krankheiten. Varizellenimpfung. Empfehlungen der Schweizerischen Kommission f\u00fcr Impffragen (SKIF) und des Bundesamtes f\u00fcr Gesundheit (BAG).","volume":"45","year":"2004","journal-title":"Bull BAG"},{"key":"R75-16-20210202","first-page":"259","article-title":"Resultados de la vacunaci\u00f3n universal a ni\u00f1os de un a\u00f1o con vacuna de varicela en Montevideo, Uruguay.","volume":"74","author":"Quian","year":"2003","journal-title":"Arch Pediatr Urug"},{"key":"R76-16-20210202","first-page":"1","article-title":"Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.","volume":"45","year":"1996","journal-title":"MMWR Recomm Rep"},{"issue":"RR05","key":"R77-16-20210202","first-page":"1","article-title":"Combination vaccines for childhood immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP) Advisory Committee on Immunization Practices.","volume":"48","year":"1999","journal-title":"MMWR Recomm Rep"},{"key":"R78-16-20210202","first-page":"717","article-title":"National state and urban area vaccination coverage among children aged 19\u201335 months\u2014United States, 2004.","volume":"54","year":"2005","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R80-16-20210202","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJMoa042271","article-title":"Decline in mortality due to varicella after implementation of varicella vaccination in the United States.","volume":"352","author":"Nguyen","year":"2005","journal-title":"N Engl J Med"},{"key":"R82-16-20210202","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/S0264-410X(02)00431-0","article-title":"The cost-effectiveness of routine childhood varicella vaccination in Germany.","volume":"21","author":"Banz","year":"2003","journal-title":"Vaccine"},{"key":"R83-16-20210202","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s10198-003-0200-7","article-title":"The burden of varicella in Germany: potential risks and economic impact.","volume":"5","author":"Banz","year":"2004","journal-title":"Eur J Health Econ"},{"key":"R84-16-20210202","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1524-4733.2005.04005.x","article-title":"The economic value of childhood varicella vaccination in France and Germany.","volume":"8","author":"Coudeville","year":"2005","journal-title":"Value Health"},{"key":"R85-16-20210202","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00019053-200422020-00005","article-title":"Economic evaluation of varicella vaccination programmes: a review of the literature.","volume":"22","author":"Hammerschmidt","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"R86-16-20210202","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1524-4733.2003.65241.x","article-title":"Validation of health economic models: the example of EVITA.","volume":"6","author":"Hammerschmidt","year":"2003","journal-title":"Value Health"},{"key":"R87-16-20210202","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2165\/00019053-200321010-00002","article-title":"Economic evaluations of varicella vaccination programmes: a review of the literature.","volume":"21","author":"Thiry","year":"2003","journal-title":"Pharmacoeconomics"},{"key":"R89-16-20210202","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00430-002-0123-4","article-title":"Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.","volume":"191","author":"Wutzler","year":"2002","journal-title":"Med Microbiol Immunol"},{"key":"R90-16-20210202","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1001\/jama.287.17.2209","article-title":"Varicella vaccine and shingles.","volume":"287","author":"Seward","year":"2002","journal-title":"JAMA"},{"key":"R91-16-20210202","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0264-410X(01)00437-6","article-title":"The cost-effectiveness of varicella vaccination in Canada.","volume":"20","author":"Brisson","year":"2002","journal-title":"Vaccine"},{"key":"R92-16-20210202","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1086\/430325","article-title":"Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992\u20132002.","volume":"191","author":"Jumaan","year":"2005","journal-title":"J Infect Dis"},{"key":"R93-16-20210202","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"R94-16-20210202","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1001\/jama.1997.03550180045035","article-title":"Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center.","volume":"278","author":"Izurieta","year":"1997","journal-title":"JAMA"},{"key":"R95-16-20210202","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1086\/422041","article-title":"An elementary school outbreak of varicella attributed to vaccine failure: policy implications.","volume":"190","author":"Lee","year":"2004","journal-title":"J Infect Dis"},{"key":"R96-16-20210202","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1542\/peds.113.3.455","article-title":"Chickenpox outbreak in a highly vaccinated school population.","volume":"113","author":"Tugwell","year":"2004","journal-title":"Pediatrics"},{"key":"R97-16-20210202","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa021662","article-title":"Outbreak of varicella at a day-care center despite vaccination.","volume":"347","author":"Galil","year":"2002","journal-title":"N Engl J Med"},{"key":"R98-16-20210202","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1086\/340868","article-title":"An outbreak of varicella among children attending preschool and elementary school in Illinois.","volume":"35","author":"Dworkin","year":"2002","journal-title":"Clin Infect Dis"},{"key":"R99-16-20210202","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine.","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"R100-16-20210202","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/clinids\/20.2.316","article-title":"Humoral and cell-mediated immune responses in healthy children after one or two doses of varicella vaccine.","volume":"20","author":"Watson","year":"1995","journal-title":"Clin Infect Dis"},{"key":"R101-16-20210202","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.291.7.851","article-title":"Effectiveness over time of varicella vaccine.","volume":"291","author":"Vazquez","year":"2004","journal-title":"JAMA"},{"key":"R102-16-20210202","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1651-2227.1991.tb11782.x","article-title":"Evaluation of live attenuated varicella vaccine (Oka-RIT strain) and combined varicella and MMR vaccination in 13-17-month-old children.","volume":"80","author":"Vesikari","year":"1991","journal-title":"Acta Paediatr Scand"},{"key":"R105-16-20210202","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/01.inf.0000195626.35239.58","article-title":"Immunogenicity and safety of two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.","volume":"25","author":"Knuf","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R106-16-20210202","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/01.inf.0000172902.25009.a1","article-title":"Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children.","volume":"24","author":"Shinefield","year":"2005","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-200707000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:47:55Z","timestamp":1786034875000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200707000-00016"}},"subtitle":["A Role for the Combined Vaccine"],"short-title":[],"issued":{"date-parts":[[2007,7]]},"references-count":79,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e3180616c8f","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2007,7]]}}}